Cargando…

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing incidence, leading to a health care problem of epidemic proportions for which no curative treatments exist. Consequently, an urge exists to better understand the pathophysiology of HFpEF. Accumulating evidence sugg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weerts, Jerremy, Mourmans, Sanne G. J., Barandiarán Aizpurua, Arantxa, Schroen, Blanche L. M., Knackstedt, Christian, Eringa, Etto, Houben, Alfons J. H. M., van Empel, Vanessa P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961612/ https://www.ncbi.nlm.nih.gov/pubmed/35204779 http://dx.doi.org/10.3390/biom12020278

Ejemplares similares

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
por: Barandiarán Aizpurua, Arantxa, et al.
Publicado: (2021)

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
por: Weerts, J, et al.
Publicado: (2023)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction
por: Luo, Hongxing, et al.
Publicado: (2022)

Association of left ventricular strain–volume loop characteristics with adverse events in patients with heart failure with preserved ejection fraction
por: Kerstens, Thijs P, et al.
Publicado: (2023)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort
por: Canto, Elisa Dal, et al.
Publicado: (2023)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross‐over study
por: Weerts, Jerremy, et al.
Publicado: (2023)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
por: Sickinghe, Ariane A., et al.
Publicado: (2019)

Increased myocardial stiffness more than impaired relaxation function limits cardiac performance during exercise in heart failure with preserved ejection fraction: a virtual patient study
por: van Loon, Tim, et al.
Publicado: (2020)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
por: Erhardsson, Mikael, et al.
Publicado: (2023)

Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
por: Bilak, Joanna M, et al.
Publicado: (2022)

The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction
por: Sandesara, Pratik B., et al.
Publicado: (2018)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
por: Sinha, Aish, et al.
Publicado: (2021)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
por: Sinha, Aish, et al.
Publicado: (2023)

Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report
por: Narang, Nikhil, et al.
Publicado: (2017)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
por: Joung, Sandy, et al.
Publicado: (2019)

Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms
por: Fopiano, Katie Anne, et al.
Publicado: (2022)

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
por: Gawalko, M, et al.
Publicado: (2023)

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, A. G., et al.
Publicado: (2020)

Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction
por: Wang, Yong, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
por: Verdonschot, Job A.J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbhbaq8bjfgfa2netpbrm3l456